Analysis
As the “Am Law Daily” blog noted last June, GlaxoSmithKline has an unusual strategy for dealing with the thousands of personal injury suits alleging that its controversial diabetes drug Avandia contributes to heart problems.
As the "Am Law Daily" blog noted last June, GlaxoSmithKline has an unusual strategy for dealing with the thousands of personal injury suits alleging that its controversial diabetes drug Avandia contributes to heart problems.
February 09, 2011 at 12:00 AM
1 minute read
Analysis
As the “Am Law Daily” blog noted last June, GlaxoSmithKline has an unusual strategy for dealing with the thousands of personal injury suits alleging that its controversial diabetes drug Avandia contributes to heart problems.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS